Canadian generic maker enters Korea with JV

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

Singapore: Montreal-based generic drug developer and marketer Pharmascience is venturing into Korea by forming a joint v...Read more

Orexigen, Takeda file lawsuit against Actavis for patent infringement

Generics |  Regulatory | By BioSpectrum Bureau  | 4 Comment | 08 Jun, 2015

Singapore: Orexigen Therapeutics and Takeda Pharmaceuticals have filed a lawsuit in US against Actavis for filing an abb...Read more

FDA warns Tianjin Zhongan for cGMP lapses

Generics |  Regulatory | By BioSpectrum Bureau  | 6 Comment | 26 Jun, 2014

Singapore: The US Food and Drug Administration (FDA) has slapped a warning letter to China based Tianjin Zhongan Pharma...Read more

Beximco pharma receives TFDA approval

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jul, 2014

Singapore: Beximco pharmaceuticals, a Bangladeshi pharma giant announced that it had received Good Manufacturing Practic...Read more

Teva to acquire migraine drug firm at $825 mn

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2014

Singapore: With the strategy to strengthen its pain management portfolio, global biopharmaceutical company, Teva Pharmac...Read more

Mayne Pharma appoints a new vice president

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2014

Singapore: Australian drug maker Mayne Pharma announced Mr Blake Cullen as the new vice president of business developmen...Read more

GSK seeks FIPB nod to hike stake in India

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jan, 2014

Singapore: British drugmaker GlaxoSmithKline has approached the Foreign Investment Promotion Board (FIPB) to hike stake ...Read more

Pharma FDI cap, right move for India

Generics |  Opinion | By Nandita Singh | 0 Comment | 31 Jul, 2012

India's pharma industry, mainly comprising generics has got a breather. The government in India has decided to cap brown...Read more

GSK CEO: London HQ 'knew nothing' of the fraud

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

Singapore: Addressing the global media for the first time after allegations were leveled out against Britain's largest d...Read more

FDA nod for Lupin's angina generic Ranolazine

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

Mumbai: Lupin Phamaceuticals has received final approval for its Ranolazine extended-release tablets, 500 mg and 1000 mg...Read more

Eli Lilly files $500 mn suit against Canada govt

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Sep, 2013

Singapore: Eli Lilly has filed a $500 million international lawsuit against the Canadian government alleging that the co...Read more

DRL launches Alchemia thrombosis generic in India

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2013

Singapore: Alchemia's commercialization partner Dr Reddy's Laboratories has launched Alchemia's FDA approved generic an...Read more

Abbott Laboratories unveils strategy for India

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jul, 2013

Singapore: Pharma major Abbott Laboratories has unveiled its strategy for the Indian market, claiming that it will push ...Read more

Pfizer to acquire Innopharma at $360 mn

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2014

Singapore: Global pharma firm, Pfizer, plans to acquire InnoPharma at approx $360 million to strengthen its generics, in...Read more

Mylan launches operations in India with 18 ARV products

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

Bangalore: Mylan Pharmaceuticals, a subsidiary of Mylan, has commenced commercial operations in India, starting with the...Read more

Mundipharma appoints John Lee as GM for SEA

Generics |  Influencers | By BioSpectrum Bureau  | 7 Comment | 06 Nov, 2013

Singapore: Asian pharmaceutical firm, Mundipharma, has promoted the general manager of Mundipharma Korea, Mr John Lee, t...Read more

Dr Reddy's launches Eszopiclone tablets in US

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Apr, 2014

Singapore: Dr Reddy's Laboratories has launched sedative drug, Eszopiclone tablets (C-IV) 1 mg, 2 mg and 3 mg, a therape...Read more

Bioscience firms queue up for Japan market

Generics |  Analysis | By BioSpectrum Bureau  | 3 Comment | 01 Jun, 2012

Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into a...Read more